Skip to main content

Table 3 Comparison between groups A versus B

From: Clinical utility of linear endosonography in patients with unexplained biliary dilatation and negative MRCP, with predictors for detection of neoplastic lesions

  Group A
No = 29
Group B
No = 32
P value
Age 60 (21–82) 59 (33–79) 0.426
Sex
 • Male 13 (44.8%) 16 (50.0%) 0.686
 • Female 16 (55.2%) 16 (50.0%)
Clinical presentation
 • Jaundice 26 (89.7%) 17 (53.1%) 0.002
 • Abdominal pain 2 (6.9%) 8 (25.0%) 0.056
 • Incidental biliary dilatation 2 (3.4%) 7 (21.9%) 0.033
Laboratory data
 • Total bilirubin 5.3 (0.4–37.0) 1.4 (0.5–39.0) 0.002
 • ALT 54.0 (21.0–201.0) 45.5(11.0–239.0) 0.466
 • AST 50.0 (23.0–288.0) 44.0(19.0–210.0) 0.355
 • Alkaline phosphatase 250 (160–1260) 190 (47–647) 0.022
CBD diameter by EUS 13.7 ± 2.92 11.55 ± 3.14 0.006
  1. Data are expressed as mean ± SD, median (range), or n (%)
  2. ALT Alanine transaminase, AST Aspartate aminotransferase